Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)

BACKGROUND: Gastric cancer (GC) is the sixth most common cancer and third leading cause of cancer-related deaths worldwide. Current treatments mainly rely on surgery- and chemotherapy-based systemic; however, the prognosis remains poor for advanced disease. Recent studies have suggested that immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao-Nan, Xie, Bin, Zhang, Ying, He, Ming-Hua, Xing, Yang, Mu, Dong-Mei, Wang, Hong, Guo, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Scientometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642438/
https://www.ncbi.nlm.nih.gov/pubmed/37970478
http://dx.doi.org/10.3748/wjg.v29.i40.5593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642438/
https://www.ncbi.nlm.nih.gov/pubmed/37970478
http://dx.doi.org/10.3748/wjg.v29.i40.5593

Ejemplares similares